Short Interest in Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Drops By 65.3%

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 95,200 shares, a drop of 65.3% from the November 15th total of 274,500 shares. Based on an average daily volume of 3,230,000 shares, the short-interest ratio is currently 0.0 days.

Quoin Pharmaceuticals Stock Performance

NASDAQ QNRX traded up $0.04 during trading on Wednesday, reaching $0.77. 334,949 shares of the company traded hands, compared to its average volume of 1,080,843. The stock’s 50 day moving average price is $0.67 and its two-hundred day moving average price is $0.64. Quoin Pharmaceuticals has a 1-year low of $0.48 and a 1-year high of $6.18. The company has a market cap of $3.89 million, a price-to-earnings ratio of -0.20 and a beta of 1.79.

Quoin Pharmaceuticals Company Profile

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.